**Author details**

Eduardo Guimarães Hourneaux de Moura\* , Bruno da Costa Martins, Guilherme Sauniti Lopes *Department of Gastroenterology, Gastrointestinal Endoscopy Unit, Hospital das Clínicas - University of São Paulo School of Medicine, São Paulo, Brazil* 

#### Ivan Roberto Bonotto Orso

*Department of Gastroenterology, Gastrointestinal Endoscopy Unit, Hospital das Clínicas - University of São Paulo School of Medicine. São Paulo, Brazil Department of Surgery, School of Medicine of the Assis Gurgacz Faculty, Gastroclínica Cascavel, Brazil* 

#### **6. References**


<sup>\*</sup> Corresponding Author

resistance and cardiometabolic risk (from the Framingham Offspring Cohort). Am J Cardiol. 2008;101(4):497–501.

[11] Rucker D, Padwal R, Li SK, et al. Long term pharmacotherapy for obesity and overweight: update and meta-analysis. Br Med J 2007;335: 1194-9.)

300 Lipoproteins – Role in Health and Diseases

Ivan Roberto Bonotto Orso

*Gastroclínica Cascavel, Brazil* 

2005;96(3):399–404.

 \*

Corresponding Author

**6. References** 

Eduardo Guimarães Hourneaux de Moura\*

Bruno da Costa Martins, Guilherme Sauniti Lopes

*Department of Gastroenterology, Gastrointestinal Endoscopy Unit,* 

*Department of Gastroenterology, Gastrointestinal Endoscopy Unit,* 

persons. Arch Intern Med. 2007;167(16):1720–8.

diabetes. Diabetes Care. 2007;30(5):1206–11.

Metab CardiovascDis. 2009;19(6):401–8.

factors. Pediatr Diabetes. 2008;9(5):464–71.

Gastroenterology 2011, 27:407–41

*Department of Surgery, School of Medicine of the Assis Gurgacz Faculty,* 

,

[1] Bogers RP, Bemelmans WJ, Hoogenveen RT, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a metaanalysis of 21 cohort studies including more than 300 000

[2] Kumar N, Thompson CC. Endoscopic solutions for weight loss. Current Opinion in

[3] McLaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight

[4] Shishehbor MH, Hoogwef BJ, Lauer MS. Association of triglyceride to HDL cholesterol

[5] McLaughlin T, Reaven G, Abbasi F, et al. Is there a simple way to identify insulin resistant individuals at increased risk of cardiovascular disease? Am J Cardiol.

[6] Tong PC, Kong AP, SoWY, et al. The usefulness of the international diabetes federation and the national cholesterol education program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2

[7] Hadaegh F, Dhalili D, Ghasemi A, et al. Triglyceride/HDLcholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr

[8] Vasques ACJ, Rosado LEFPM, Rosado GP, et al. Indicadores do perfil lipídico plasmático

[9] Quizada Z, Paoli M, Zerpa Y, et al. The triglyceride/HDL cholesterol ratio as a marker of cardiovascular risk in obesechildren; association with traditional and emergent risk

[10] Kannel WB, Vasan RS, Keyes MJ, et al. Usefulness of the triglyceride high density lipoprotein versus the cholesterol high density lipoprotein ratio for predicting insulin

relacionados à resistência á insulina. Rev Assoc Méd Bras. 2009;55(3):342–6.

individuals who are insulin resistant. Ann Intern Med. 2003;139:802–9.

ratio with heart rate recovery. Diabetes Care. 2004;27(4):936–41.

*Hospital das Clínicas - University of São Paulo School of Medicine, São Paulo, Brazil* 

*Hospital das Clínicas - University of São Paulo School of Medicine. São Paulo, Brazil* 

**Author details** 

